These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32415074)

  • 1. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine.
    Gouma S; Weirick M; Hensley SE
    Nat Commun; 2020 May; 11(1):2445. PubMed ID: 32415074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
    Allen JD; Ross TM
    Front Immunol; 2021; 12():707339. PubMed ID: 34475872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Sia ZR; He X; Zhang A; Ang JC; Shao S; Seffouh A; Huang WC; D'Agostino MR; Teimouri Dereshgi A; Suryaprakash S; Ortega J; Andersen H; Miller MS; Davidson BA; Lovell JF
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.
    Gouma S; Zost SJ; Parkhouse K; Branche A; Topham DJ; Cobey S; Hensley SE
    Clin Infect Dis; 2020 Sep; 71(6):1447-1453. PubMed ID: 31598646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.
    Ursin RL; Liu H; Powell HR; Westerbeck JW; Shaw-Saliba K; Sylvia KE; Fenstermacher KJ; Mehoke T; Thielen P; Rothman RE; Pekosz A; Klein SL
    J Infect Dis; 2020 Sep; 222(8):1371-1382. PubMed ID: 32496543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Antigenic Mismatch of the H3N2 Component of the 2019 Southern Hemisphere Influenza Vaccine.
    Gouma S; Weirick M; Hensley SE
    Clin Infect Dis; 2020 May; 70(11):2432-2434. PubMed ID: 31400756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
    J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza H3N2 Vaccines: Recent Challenges.
    Mostafa A; Pleschka S
    Trends Microbiol; 2018 Feb; 26(2):87-89. PubMed ID: 29268980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
    Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
    Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
    Gouma S; Furey C; Santos JJS; Parkhouse K; Weirick M; Muramatsu H; Pardi N; Fan SHY; Weissman D; Hensley SE
    J Virol; 2023 Jan; 97(1):e0172322. PubMed ID: 36533954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility.
    Gouma S; Kim K; Weirick ME; Gumina ME; Branche A; Topham DJ; Martin ET; Monto AS; Cobey S; Hensley SE
    Nat Commun; 2020 Sep; 11(1):4566. PubMed ID: 32917903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.